- Home
- TCRT vs FLZH Comparison
TCRT vs FLZH Comparison
Compare TCRT & FLZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.76
N/A
Current Price
$0.98
Company Overview
Basic Information| Metric | TCRT | FLZH |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 4.1M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TCRT | FLZH |
|---|---|---|
| Price | $1.76 | $0.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 170.4K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.66 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,900,000.00 | ★ $17,399,438.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.75 | $0.97 |
| 52 Week High | $4.57 | $2.88 |
Technical Indicators
Market Signals| Indicator | TCRT | FLZH |
|---|---|---|
| Relative Strength Index (RSI) | 29.15 | 25.13 |
| Support Level | N/A | N/A |
| Resistance Level | $2.02 | $1.85 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.37 | 6.51 |
Price Performance
Historical Comparison TCRT
FLZH
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.